Free Trial

AxoGen (AXGN) SEC Filings & 10K Form

AxoGen logo
$12.90 +0.15 (+1.18%)
(As of 11/20/2024 ET)

Recent AxoGen SEC Filings

DateFilerForm TypeView
11/07/2024
9:52 AM
AxoGen (Subject)
Zaderej Karen L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
6:08 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/13/2024
3:30 PM
AxoGen (Issuer)
DeVinney Erick Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
3:00 PM
ArrowMark Colorado Holdings LLC (Filed by)
AxoGen (Subject)
Form SC 13G/A
09/06/2024
6:09 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2024
3:33 PM
AxoGen (Subject)
Zaderej Karen L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
7:58 PM
AxoGen (Issuer)
Levine Alan M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:11 PM
AxoGen (Issuer)
NEELS GUIDO J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:13 PM
AxoGen (Issuer)
JOHNSON JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:52 PM
AxoGen (Issuer)
Burke William P. Mr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
7:33 PM
AxoGen (Issuer)
THOMAS PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
6:52 PM
AxoGen (Issuer)
TYNDALL JOSEPH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
4:18 PM
AxoGen (Issuer)
Wendell Amy McBride (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
3:31 PM
AxoGen (Subject)
Donovan Michael Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
9:59 AM
AxoGen (Subject)
Zaderej Karen L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/09/2024
3:36 PM
AxoGen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/09/2024
3:15 PM
AxoGen (Issuer)
DALE MICHAEL D (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/09/2024
3:20 PM
AxoGen (Issuer)
DALE MICHAEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
6:14 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/10/2024
5:10 PM
AxoGen (Issuer)
Weiler Kathy Johnson (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:11 PM
AxoGen (Issuer)
TYNDALL JOSEPH A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:13 PM
AxoGen (Issuer)
NEELS GUIDO J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:15 PM
AxoGen (Issuer)
Levine Alan M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:19 PM
AxoGen (Issuer)
THOMAS PAUL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:20 PM
AxoGen (Issuer)
JOHNSON JOHN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:22 PM
AxoGen (Issuer)
Burke William P. Mr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2024
5:24 PM
AxoGen (Issuer)
Wendell Amy McBride (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:15 PM
AxoGen (Filer)
Form 8-K/A
06/07/2024
3:31 PM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2024
3:49 PM
AxoGen (Issuer)
Freitag Gregory Gene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
6:00 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
11:15 PM
AxoGen (Filer)
Form EFFECT
04/24/2024
6:32 AM
AxoGen (Filer)
Form DEF 14A
04/24/2024
6:21 AM
AxoGen (Filer)
Form ARS
04/04/2024
3:30 PM
AxoGen (Filer)
Form PRE 14A
03/29/2024
3:16 PM
AxoGen (Filer)
Form S-3/A
03/25/2024
8:43 PM
AxoGen (Issuer)
Zaderej Karen L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
8:37 PM
AxoGen (Issuer)
Scopelianos Angelo (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
8:40 PM
AxoGen (Issuer)
DeVinney Erick Wayne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
8:22 PM
AxoGen (Issuer)
Donovan Michael Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2024
11:15 PM
AxoGen (Filer)
Form EFFECT
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

03/08/2024
4:31 PM
AxoGen (Issuer)
Freitag Gregory Gene (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
4:33 PM
AxoGen (Issuer)
Donovan Michael Patrick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/08/2024
3:38 PM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2024
5:12 PM
AxoGen (Subject)
Donovan Michael Patrick (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2024
7:59 AM
AxoGen (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/06/2024
7:45 AM
AxoGen (Filer)
Form POS AM
03/06/2024
7:53 AM
AxoGen (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/05/2024
6:16 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:22 PM
ArrowMark Colorado Holdings LLC (Filed by)
AxoGen (Subject)
Form SC 13G/A
02/12/2024
12:21 PM
AxoGen (Subject)
MORGAN STANLEY (Filed by)
Form SC 13G
02/06/2024
4:06 PM
AxoGen (Subject)
MARTINEZ MARIA D. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/02/2024
8:29 AM
AxoGen (Subject)
Soleus Capital Master Fund, L.P. (Filed by)
Form SC 13G/A
01/11/2024
4:07 PM
AxoGen (Issuer)
Kemp Jens (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2024
4:10 PM
AxoGen (Issuer)
Weiler Kathy Johnson (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/11/2024
4:14 PM
AxoGen (Issuer)
Weiler Kathy Johnson (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
6:05 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
4:21 PM
AxoGen (Filer)
Form 8-K/A
01/04/2024
4:45 PM
AxoGen (Issuer)
Naor Nir (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/04/2024
4:48 PM
AxoGen (Issuer)
Naor Nir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2024
3:56 PM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/26/2023
3:21 PM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
3:38 PM
AxoGen (Subject)
MARIANI PETER J (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/06/2023
6:15 AM
AxoGen (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AXGN) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners